A detailed history of Amalgamated Bank transactions in Liquidia Corp stock. As of the latest transaction made, Amalgamated Bank holds 1,656 shares of LQDA stock, worth $18,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,656
Previous 1,656 -0.0%
Holding current value
$18,232
Previous $20,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$11.35 - $16.73 $49,497 - $72,959
-4,361 Reduced 72.48%
1,656 $24,000
Q4 2023

Feb 06, 2024

SELL
$5.77 - $12.19 $2,844 - $6,009
-493 Reduced 7.57%
6,017 $72,000
Q2 2023

Aug 11, 2023

BUY
$6.63 - $9.9 $3,208 - $4,791
484 Added 8.03%
6,510 $51,000
Q1 2023

May 02, 2023

SELL
$5.72 - $7.91 $5,948 - $8,226
-1,040 Reduced 14.72%
6,026 $42,000
Q3 2022

Nov 09, 2022

BUY
$3.73 - $8.39 $279 - $629
75 Added 1.07%
7,066 $38,000
Q2 2022

Aug 15, 2022

BUY
$3.37 - $7.55 $23,559 - $52,782
6,991 New
6,991 $30,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.